ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Vivoryon Therapeutics Nv

Vivoryon Therapeutics Nv (0R3M)

4.71
0.00
(0.00%)
Closed November 22 10:30AM

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20162017201820192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 44k01,00014k6k10.76M0-3.62M
Operating Income -14.56M-8.77M-7.64M-9.67M-16.01M-12.8M-29.11M-28.84M
Pre Tax Income -14.51M-8.83M-7.7M-9.75M-16.51M-12.22M-28.36M-28.58M
Net Income -14.51M-7.73M-7.7M-9.75M-16.51M-12.66M-28.16M-28.34M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.773-0.942-0.938-0.792-0.827-0.631-1.168-1.087
EBIT -14.56M-8.77M-7.64M-9.67M-16.01M-12.8M-29.11M-28.84M
EBITDA -14.46M-8.66M-7.61M-9.64M-15.87M-12.63M-28.99M-28.72M